Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pituitary Neoplasms × Cefdinir × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pituitary Neoplasms 1

Interventions

Cabergoline 7 pasireotide 4 Surgical Procedures, Operative 4 Propofol 3 Dexmedetomidine 3 lanreotide 2 Temozolomide 2 Sevoflurane 2 Saline Solution 2 Rosiglitazone 2 Radiotherapy 2 Radiosurgery 2 Proton Therapy 2 Hydrocortisone 2 Human Growth Hormone 2 Dexamethasone 2 Desflurane 2 Aminolevulinic Acid 2 pegvisomant 1 parecoxib 1 lutetium Lu 177 dotatate 1 loxoprofen 1 farletuzumab 1 entinostat 1 corticorelin ovine 1 Yoga 1 Visual Field Tests 1 Visual Acuity 1 Trimethoprim 1 Transcranial Magnetic Stimulation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03014687 2018-08-15

POET

St. Joseph's Hospital and Medical Center, Phoenix

Phase 4 Recruiting

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡